![ExpreS2ion announces formation of Infectious Diseases Scientific Advisory Board - ExpreS2ion Biotechnologies ExpreS2ion announces formation of Infectious Diseases Scientific Advisory Board - ExpreS2ion Biotechnologies](https://mb.cision.com/Public/14402/3730060/bd1b93cccdbb1d38_400x400ar.jpg)
ExpreS2ion announces formation of Infectious Diseases Scientific Advisory Board - ExpreS2ion Biotechnologies
![ExpreS2ion publishes video from company presentation at a Danish investor event - ExpreS2ion Biotechnologies ExpreS2ion publishes video from company presentation at a Danish investor event - ExpreS2ion Biotechnologies](https://mb.cision.com/Public/14402/3225533/a41e377c26efbacc_400x400ar.jpg)
ExpreS2ion publishes video from company presentation at a Danish investor event - ExpreS2ion Biotechnologies
![Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen - ExpreS2ion Biotechnologies Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen - ExpreS2ion Biotechnologies](https://expres2ionbio.com/wp-content/uploads/2018/02/ExpreS2_FEB2018_N%C3%A4ringsliv_page-13.jpg)
Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen - ExpreS2ion Biotechnologies
![ExpreS2ion publishes video from COVID-19-focused company presentation at Japanese event - ExpreS2ion Biotechnologies ExpreS2ion publishes video from COVID-19-focused company presentation at Japanese event - ExpreS2ion Biotechnologies](https://mb.cision.com/Public/14402/3230612/89280e3ecf304e18_400x400ar.jpg)
ExpreS2ion publishes video from COVID-19-focused company presentation at Japanese event - ExpreS2ion Biotechnologies
ExpreS2ion Biotech : Analysguiden announces new research report with the target price for ExpreS2ion increased to 49 SEK per share -April 22, 2021 at 05:01 am EDT | MarketScreener
![ExpreS2ion enters multi-product agreement with US-based Integrated BioTherapeutics for expansion of their commercial reagents portfolio - Integrated biotherapeutics ExpreS2ion enters multi-product agreement with US-based Integrated BioTherapeutics for expansion of their commercial reagents portfolio - Integrated biotherapeutics](https://www.integratedbiotherapeutics.com/wp-content/uploads/2021/08/Logo-Update.png)